Search
- Dec 21, 2023
Leveraging enzymes to help scale RNA therapies and other biocatalyst use cases with the CEO of Codexis
Stephen Dilly describes how Codexis is trying help RNA companies use enzymes to more efficiently make oligonucleotides.
Also look for unique social pages for BiotechTV U.
#1. Ultragenyx's Emil Kakkis on Angelman syndrome data, rare disease treatment modalities, and more
#2. The CEO of Madrigal on the launch of Rezdiffra for NASH liver disease
#3. Sutro Biopharma's CEO on ADCs, non-cell protein synthesis, and more
#4. Verve Therapeutics' CEO on today's gene editing clinical trial pause
#5. Daphne Zohar on becoming the CEO of Seaport Therapeutics and a $100M series A